Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Chemical (specialty)

Article Abstract:

Statistics of some of the companies in the Specialty chemicals industry and their securities rankings as of December 17, 2004 are furnished. The industry is expected to continue its course of reporting improved performance. Some of the stocks in the sector are likely to show marked appreciation in the 3 to 5 years time frame.

Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
United States, Forecasts, trends, outlooks, CHEMICALS AND ALLIED PRODUCTS, Industry Overview, Specialty chemicals industry, Industry forecasts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Medarex, Inc

Article Abstract:

The shares of Medarex Inc. have a solid price appreciation potential over the 2010-2012 timeframe. The Princeton, New Jersey-based company develops drugs using its patented human monoclonal antibody production technology.

Author: Rosner, Adam
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Biological products exc. diagnostic, Evaluation, Stocks, Biological products industry, Stock prices, Medarex Inc., MEDX, Analyst report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Securities, Company securities
Similar abstracts:
  • Abstracts: Chemical (specialty). part 6 Chemical (Specialty)
  • Abstracts: Dow Chemical. Airgas, Inc
  • Abstracts: Medical services industry. XenoPort, Inc. NitroMed, Inc
  • Abstracts: Volt Info. Sci. Manpower Inc. Gevity HR Inc
  • Abstracts: Smith (A.O.). Clean Harbors Inc
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.